Oxygenators Market worth US$ 348.4 Million by 2028 - Exclusive Report by IMARC Group

According to IMARC Group's latest report, titled "𝐎𝐱𝐲𝐠𝐞𝐧𝐚𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀, 𝗦𝗵𝗮𝗿𝗲, 𝗦𝗶𝘇𝗲, 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗮𝗻𝗱 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 2023-2028", the oxygenators market reached US$ 244.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 348.4 Million by 2028, exhibiting a CAGR of 5.9% during 2023-2028.

An oxygenator represents a medical device that is routinely used in medical settings to help exchange oxygen and carbon dioxide from the patient blood during surgical procedures. The device is utilized in conjunction with a heart-lung machine to facilitate gas exchange during operations in which the blood flow is interrupted or stopped. In addition, these devices are widely used to manage heart-related disorders, including cardiopulmonary, respiratory, and pulmonary disorders. Consequently, they are extensively adopted in hospitals, clinics, and other healthcare establishments across the globe.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗳𝗿𝗲𝗲 𝘀𝗮𝗺𝗽𝗹𝗲 𝗯𝗿𝗼𝗰𝗵𝘂𝗿𝗲: https://www.imarcgroup.com/oxygenators-market/requestsample

𝐆𝐥𝐨𝐛𝐚𝐥 𝐎𝐱𝐲𝐠𝐞𝐧𝐚𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬

The increasing incidences of several coronary, orthopedic, and cardiovascular diseases among the masses, owing to the sedentary lifestyles led by individuals, are among the key factors stimulating the oxygenators market. Moreover, the growing geriatric population, which is susceptible to developing these diseases, is acting as another significant growth-inducing factor. Besides this, the inflating government investments in healthcare digitization, advanced infrastructure setup, and continuous product innovations are positively influencing the global market. Furthermore, the escalating demand for oxygenator devices across healthcare facilities across various countries, owing to improved healthcare settings, is also propelling the market growth.

Apart from this, the increasing mergers and acquisitions (M&As) between key players to innovate state-of-the-art medical devices, the growing cases of severe COVID-19 across the globe, the launch of favorable healthcare reimbursement initiatives, and extensive R&D activities conducted by key players to introduce advanced medical devices in the market are further fueling the global market. Additionally, the rising usage of these devices in numerous critical surgeries, such as cardiopulmonary bypass grafts (CABG) and coronary artery bypass grafts (CABG), is anticipated to fuel the oxygenators market over the forecasted period.

𝗖𝗵𝗲𝗰𝗸𝗼𝘂𝘁 𝗡𝗼𝘄: https://www.imarcgroup.com/checkout?id=6448&method=1

𝐆𝐥𝐨𝐛𝐚𝐥 𝐎𝐱𝐲𝐠𝐞𝐧𝐚𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 2023-2028 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

The competitive landscape of the oxygenators market has been studied in the report with the detailed profiles of the key players operating in the market.

𝗦𝗼𝗺𝗲 𝗼𝗳 𝘁𝗵𝗲𝘀𝗲 𝗸𝗲𝘆 𝗽𝗹𝗮𝘆𝗲𝗿𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:

Braile Biomédica, Chalice Medical Ltd, Eurosets S.r.l., Getinge AB, Livanova Plc, Medtronic plc, MicroPort, Nipro Corporation, Senko Medical Instrument Mfg. Co. Ltd., Terumo Medical Corporation (Terumo Corporation) and Xenios AG (Fresenius Medical Care AG & Co. KGaA).

𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

The report has segmented the interior design software market bases on the age group and application.

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐓𝐲𝐩𝐞:

Membrane Oxygenator
Bubble Oxygenator

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐀𝐠𝐞 𝐆𝐫𝐨𝐮𝐩:

Neonates
Pediatric
Adults

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧:

Respiratory
Cardiac
Extracorporeal Cardiopulmonary
Resuscitation (ECPR)

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐑𝐞𝐠𝐢𝐨𝐧:

North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

𝗔𝘀𝗸 𝗔𝗻𝗮𝗹𝘆𝘀𝘁 𝗳𝗼𝗿 𝟭𝟬% 𝗳𝗿𝗲𝗲 𝗰𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗿𝗲𝗽𝗼𝗿𝘁: https://www.imarcgroup.com/oxygenators-market

𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐓𝐨𝐩 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭-
https://www.openpr.com/news/2930611/virtual-reality-vr-in-healthcare-market-size-worth-us-3-366-1

https://www.openpr.com/news/2932947/us-43-0-billion-advanced-metering-infrastructure-ami-market

https://www.openpr.com/news/2985533/direct-carrier-billing-platform-market-to-cross-us-716-5

https://www.linkedin.com/pulse/global-board-games-market-reach-value-us-297-billion-2028-purohit/

https://www.linkedin.com/pulse/global-document-management-system-industry-report-imarc-suraj-purohit/

https://www.linkedin.com/pulse/global-same-day-delivery-market-report-overview-suraj-purohit/

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝗦:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 |
Europe & Africa: +44-753-713-2163 |
Asia: +91-120-433-0800

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.